We welcome the European Commission’s initiative to create a Pharmaceutical Strategy that envisions ensuring patient’s access to medicines across Europe while at the same time creating an environment which fosters the competitiveness of the European pharmaceutical industry in the global context.
As we acknowledge the difficulty to elaborate these aspects in the form of a multiple choice system, we would like to further elaborate on certain aspects of the four categories of the survey that we deem important to achieve the goals set out in the Roadmap.